Enhancing Efficacy of Mango Polyphenols in Lean and Obese
Enhancing Efficacy of Mango Phytochemicals in Cognitive Function and Cardiometabolic Health in Lean and Obese
1 other identifier
interventional
100
1 country
1
Brief Summary
The objective of this research is to determine beneficial impact of mango phytochemicals in lean and obese individuals for cognitive function and gut health. Investigate how obesity impacts the efficacy of mango polyphenols on cognitive function and health. Investigate the ability of probiotic bacteria to optimize the absorption and efficacy of mango phytochemicals in lean and obese individuals.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for phase_1 obesity
Started Sep 2018
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
September 30, 2018
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 30, 2019
CompletedStudy Completion
Last participant's last visit for all outcomes
December 28, 2019
CompletedFirst Submitted
Initial submission to the registry
July 6, 2021
CompletedFirst Posted
Study publicly available on registry
July 21, 2021
CompletedJuly 21, 2021
July 1, 2021
1 year
July 6, 2021
July 16, 2021
Conditions
Outcome Measures
Primary Outcomes (3)
Cognitive Function (NeuroTracker)
NeuroTracker: Ten sessions should be completed between days 43 and 56. Fill out the NeuroTracker questionnaire to assess their emotional, mental, and physical state.
From Week 6 to Week 8
Cognitive Function (The Trail Making Test)
The Trail Making Test (TMT A\&B) On Days 1 and 54, Assessed the cognitive function of the subjects by giving them these tests. The TMT A\&B Test assesses measure of attention, speed, mental flexibility, spatial organization, visual pursuits, recall, and recognition.
At baseline and week 8
Cognitive Function (the Wechsler Adult Scale-Revised Digit Span test)
The Wechsler Adult Scale-Revised Digit Span test: On Days 1 and 54, Assessed the cognitive function of the subjects by giving them these tests. The Wechsler Adult Scale-Revised Digit Span is a measure of mental tracking, memory, and mental flexibility.
At baseline and week 8
Secondary Outcomes (3)
Changes from baseline in the levels of Inflammatory biomarkers in plasma
At baseline and week 8
Change from baseline in the levels of metabolites of gallic acid in urine and plasma after mango intake.
At baseline and week 8
Change from baseline in gut microbiota composition in stool samples
At baseline and week 8
Study Arms (4)
Lean/Placebo Capsule
PLACEBO COMPARATORParticipants (Lean:BMI 18-23) will be asked to take 400g of mango and a placebo capsule every day for 8 weeks
Lean/Probiotics
EXPERIMENTALParticipants (Lean:BMI 18-23) will be asked to take 400g of mango and a probiotic capsule every day for 8 weeks
Obese/Placebo Capsule
EXPERIMENTALParticipants (Obese:BMI 27-35) will be asked to take 400g of mango and a placebo capsule every day for 8 weeks
Obese/Probiotics
EXPERIMENTALParticipants (Obese:BMI 27-35) will be asked to take 400g of mango and a probiotic capsule every day for 8 weeks
Interventions
Eligibility Criteria
You may qualify if:
- Males or females
- BMI between 18-23 and 27-35
You may not qualify if:
- History of acute cardiac event, stroke, or cancer
- Alcohol or substance abuse within the last 6 months
- Pregnancy or lactation (or planned pregnancy)
- No recurrent hospitalizations within the last 6 months
- Allergy against any of the study treatments (mango or probiotics)
- Liver or renal dysfunction
- Hepatitis B or C, HIV
- Currently smoking more than 1 pack/week
- History of dizziness/fainting during/after blood draws
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Texas A&M University
College Station, Texas, 77845, United States
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Susanne Talcott, Ph.D
Texas A&M University
Study Design
- Study Type
- interventional
- Phase
- phase 1
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Purpose
- TREATMENT
- Intervention Model
- FACTORIAL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Assoc. Professor
Study Record Dates
First Submitted
July 6, 2021
First Posted
July 21, 2021
Study Start
September 30, 2018
Primary Completion
September 30, 2019
Study Completion
December 28, 2019
Last Updated
July 21, 2021
Record last verified: 2021-07